Stockholm, Moscow January 2013.
The Swedish medtech company Bactiguard has signed an exclusive co-operation with Intermedservice, IMS, one of the largest healthcare distributors in Russia with a turnover of more than €300 million. Intermedservice is present in Russia and the whole CIS region. IMS has now the exclusivity to sell the entire line of Bactiguard´s products on the Russian medical device market, which is estimated to show strong growth over the next couple of years.
For Bactiguard, who signed similar contracts with China and India last year, this is a very important milestone. This almost completes the coverage of the BRIC-countries (Brazil, Russia, India and China), where only Brazil remains uncovered, but is a target for 2013. With distribution agreements set for India, China and now also Russia, the potential for continued increase in sales is very large.
“Bactiguard´s unique coating that prevents bacteria from adhesion and forming of biofilms has a large role to fill in these markets” says Olof Sandén, Vice President of Bactiguard, who is very happy and proud of the cooperation with Intermedservice, IMS. “IMS will open up the Russian market to us and that we together can improve patient safety in Russia with our infection protection portfolio. Health care associated infections (HCAI) are the fourth largest cause of death in the world and we have a clinically proven solution that saves lives all over the world. I am very glad and proud that we now contribute to improved health care in this region”.
The Russian medical device market is currently worth approximately 4,9 billion US dollar and will continue to grow according to Andrey Skvortsov, MD, CEO of IMS, who embraces the cooperation with Bactiguard. “In Russia, health care associated infections and the use of antibiotics is rising. Therefore I am very much looking forward to this partnership with Bactiguard whose products not only prevent infections, but also reduces the use of antibiotics and saves health care expenditures. We are convinced that the Bactiguard products will be most welcome in the Russian Health Care system”.
Press contact:
Linda Nyberg, Vice President International Affairs
Tel: +46 8 440 58 64
www.bactiguard.com
JSC “Intermedservice” company” (IMS) is one of leading Russian companies in the field of researching and integration of innovative medical technologies into Russian medical practice. IMS is premier importer and distributor of medical equipment, disposables and pharmaceutical products all over Russia. Company was founded in 1991 has great experience in the design, construction and equipping of healthcare facilities, “turnkey” delivery and maintenance of medical equipment, computerization, provision of medicines and disposables.
IMS covers the whole territory of Russia – 16 regional branches supply not only Sales but also technical service and start-up installation. Total staff of the company is over 1,500 employees, including medical technologists, engineers, designers, experts in the development of regional target programs.
IMS contributes to the development of National Healthcare Service by working out, advancing and implementing its own innovative programs like: Children’s regional clinical hospital, Oncology Center, Travelling Consultative and Diagnostic Center for Russian railways etc. JSC “Intermedservice” company” acts as a conductor of modern medical technologies, as an integrated provider of high-quality medical equipment, pharmaceuticals and other medical products. Comprehensive approach makes the company an acknowledged leader in the National medical market.
Bactiguard provides world-leading solutions preventing health care associated infections – the 4th largest cause of death in the western world. By using Bactiguard technology Governments can reduce healthcare cost, lower the use of antibiotics and save lives. The Bactiguard technology consists of an extremely thin noble metal coating that reduces bacterial adhesion and is biocompatible. It can be used on all sorts of medical devices. The Bactiguard® coated urinary catheter has since 1995 been used by more than 125 million patients in the US. Today Bactiguard offers a full range portfolio within infection prevention in the urinary tract, respiratory tract and blood stream.